My Link in Bio Page
Check out my Link in Bio page to learn more.
Related Articles
Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores
This study aims to characterize the individual-level agreement of polygenic risk scores for coronary heart disease that perform similarly at the population level.
Mortality and Comorbidities with COPD
Panelists discuss current statistics indicating that COPD is one of the top three leading causes of death worldwide, with high morbidity and mortality rates, particularly…
JPM 2025: What’s slated for the San Francisco conference
The 43rd annual J.P. Morgan Healthcare Conference will feature presentations from more than 500 private and public companies.
Exercise Prior to Cancer Diagnosis May Help Slow Disease Progression
THURSDAY, Jan. 9, 2025 (HealthDay News) — Exercising now can increase your chances of successfully fighting cancer in the future.Even low levels of exercise pr
An early warning system could help to protect resident doctor welfare
NHS employers need a proactive and consistent approach to protecting the mental health of resident doctors, write Alexander Mafi and Jaya Sharma “No one else…
Delaying Progression from Smoldering to Active Multiple Myeloma
Daratumumab is an anti-CD38 monoclonal antibody approved for treatment of active multiple myeloma. Smoldering myeloma, defined as monoclonal protein
Homepage – AMA End the Epidemic
“This report highlights that the physician community is working on multiple fronts to remove barriers to evidence-based care for patients with substance use disorders and…
Smart glasses enter new era with sleeker designs, lower prices
Producers of hi-tech connected eyewear are multiplying their innovations with increasingly discreet models in an attempt to make a difference in a highly competitive —…
How New Wearable Tech Targets Brain Waves for Better Sleep – WSJ’s The Future of Everything – WSJ Podcasts
Do you have trouble falling asleep? If meditation apps and sleep trackers aren’t cutting it, now there’s technology designed to help users not only nod…
Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease
Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease.
